Effect of Radioactive Iodine Therapy on Cancer‐Specific Survival of Papillary Thyroid Carcinoma With T4aM0 Stage

Documenti analoghi

• Association of Radioactive Iodine Administration With Outcome Among Patients With Low‐Risk Differentiated Thyroid Cancer: A Real‐World Data Analysis
  di: Yang Xu, et al.
  Pubblicazione: (2024)
• Exploring the Molecular Features and Clinicopathological Correlations of Diffuse Sclerosing Papillary Thyroid Carcinoma
  di: Yanhui Zhang, et al.
  Pubblicazione: (2025)
• CD105 (Endoglin) Expression as a Prognostic Marker in Aggressive Papillary Thyroid Carcinoma
  di: İlker Çordan, et al.
  Pubblicazione: (2025)
• Responses to Comment on ‘Second Primary Papillary Thyroid Carcinoma: Insights From Competing Risk Analysis and Post‐RAIT’
  di: Mingjun Wang, et al.
  Pubblicazione: (2025)
• Quality of Life and Decision Regret Risk in Graves' Disease After Radioactive Iodine Therapy: A Prospective Cohort Study
  di: Qian Liu, et al.
  Pubblicazione: (2026)